In the context of a project to benchmark anti-dementia drug prescribing practice against standards derived from evidence-based guidelines, the authors sought to estimate the proportion of people with dementia who were receiving treatment with an anti-dementia drug and whether this varied across Primary Care Trust (PCT) populations. They also explored the relative proportion of prescriptions for each anti-dementia drug, and the source of these prescriptions - GPs, Mental Health Trusts or acute Trusts.
CITATION STYLE
Perecherla, S., Paton, C., Shingleton-Smith, A., & Barnes, T. R. E. (2009). Variations in anti-dementia drug prescribing. Progress in Neurology and Psychiatry, 13(4), 30–33. https://doi.org/10.1002/pnp.131
Mendeley helps you to discover research relevant for your work.